| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 11.070 | 39.659 | 29.901 | 26.600 |
| Total Income - EUR | - | - | - | - | - | - | 11.070 | 39.659 | 29.901 | 26.600 |
| Total Expenses - EUR | - | - | - | - | - | - | 10.288 | 21.970 | 26.333 | 18.832 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 782 | 17.689 | 3.568 | 7.768 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 677 | 17.294 | 3.274 | 6.986 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Spitex - Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 1.351 | 19.647 | 1.361 | 7.009 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 17.294 | 485 | 1.055 |
| Cash | - | - | - | - | - | - | 1.351 | 2.353 | 876 | 5.953 |
| Shareholders Funds | - | - | - | - | - | - | 717 | 18.013 | -2.600 | 4.400 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 633 | 1.634 | 3.962 | 2.609 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Spitex - Med S.r.l.